59
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID-19 is characterized by excessive production of pro-inflammatory cytokines and acute lung damage associated with patient mortality. While multiple inflammatory cytokines are produced by innate immune cells during SARS-CoV-2 infection, we found that only the combination of TNF-α and IFN-γ induced inflammatory cell death characterized by pyroptosis, apoptosis, and necroptosis (PANoptosis). Mechanistically, TNF-α and IFN-γ co-treatment activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD–mediated PANoptosis. TNF-α and IFN-γ caused a lethal cytokine shock in mice that mirrors the tissue damage and inflammation of COVID-19, and inhibiting PANoptosis protected mice from this pathology and death. Furthermore, treating with neutralizing antibodies against TNF-α and IFN-γ protected mice from mortality during SARS-CoV-2 infection, sepsis, hemophagocytic lymphohistiocytosis, and cytokine shock. Collectively, our findings suggest that blocking the cytokine-mediated inflammatory cell death signaling pathway identified here may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.

          Highlights

          • Of several cytokines tested, only synergism of TNF-α and IFN-γ induces PANoptosis

          • TNF-α and IFN-γ–mediated PANoptosis perpetuates cytokine storm

          • TNF-α and IFN-γ shock mirrors cytokine storm syndromes, including COVID-19

          • Neutralizing TNF-α and IFN-γ protects against SARS-CoV-2, HLH, and sepsis in mice

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          Cell
          Elsevier Inc.
          0092-8674
          1097-4172
          19 November 2020
          19 November 2020
          Affiliations
          [1 ]Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [2 ]Department of Microbiology, Immunology, & Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 38163, USA
          [3 ]The Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [4 ]Hartwell Center for Bioinformatics & Biotechnology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [5 ]Animal Resources Center and Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [6 ]Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          Author notes
          []Lead contact; correspondence to: Thirumala-Devi Kanneganti Department of Immunology, St. Jude Children's Research Hospital, MS #351, 262 Danny Thomas Place , Memphis TN 38105-3678, Tel: (901) 595-3634; Fax. (901) 595-5766.
          [#]

          Equal Contribution

          Article
          S0092-8674(20)31542-7
          10.1016/j.cell.2020.11.025
          7674074
          c2be6237-92a5-4bab-b027-ebe10220c2f5
          © 2020 Elsevier Inc.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 21 September 2020
          : 22 October 2020
          : 13 November 2020
          Categories
          Article

          Cell biology
          Cell biology

          Comments

          Comment on this article